Organization
Cellcolabs Clinical SPV Limited
2 clinical trials
Clinical trial
An Open-Label Single-Arm Phase I/IIa Study to Evaluate the Safety of Human Allogenic Bone-Marrow-Derived Mesenchymal Stromal Cell Product StromaForte in Patients With Aging FrailtyStatus: Recruiting, Estimated PCD: 2024-11-28
Clinical trial
An Open-Label Single-Arm Phase I/IIa Study to Evaluate the Safety of Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product StromaForte for the Treatment of Knee OsteoarthritisStatus: Recruiting, Estimated PCD: 2024-11-08